Physician

Ajsza Matela, MD

According to 2025 Medicare claims, Ajsza Matela, MD (NPI: 1124366869) practices critical care (intensivists) in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Dutchess, NY. This provider's primary affiliated billing organization is WESTCHESTER MEDICAL CENTER ADVANCED PHYSICIAN SERVICES, PC (NPI: 1912131392; TIN: 26-4709927) and primary practice location at 12601-1154.

Matela's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 148 traditional Medicare patients, billed 485 HCPCS/CPT codes, and received $41,563 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 375 prescription claims across 80 beneficiaries totaling $118,949 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 14 claims. Open Payments data shows 29 records totaling $647. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $21,601 and ending at $41,563. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $27,321 and ending at $118,949. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $768 to $8,979.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	105	280	$21,601
2017	240	759	$63,844
2018	244	799	$68,873
2019	218	667	$64,871
2020	166	438	$43,815
2021	67	153	$8,023
2022	182	486	$45,131
2023	157	455	$33,448
2024	148	485	$41,563

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	53	215	$27,321
2017	149	804	$129,560
2018	202	1,307	$203,051
2019	175	1,326	$238,888
2020	126	887	$178,004
2021	15	28	$4,580
2022	44	153	$47,286
2023	64	329	$107,341
2024	80	375	$118,949

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	21	$53
2021	N/R	N/R	N/R
2022	N/R	13	$1,266
2023	N/R	N/R	N/R
2024	N/R	14	$981

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	30	31	$143
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	24	24	$134
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	45	47	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	42	73	$105
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	47	122	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	1,530	$31,857
Incruse Ellipta	Umeclidinium Bromide	67	2,370	$27,231
Breo Ellipta	Fluticasone/Vilanterol	26	780	$10,048
Symbicort	Budesonide/Formoterol Fumarate	30	1,200	$9,166
Albuterol Sulfate Hfa	Albuterol Sulfate	97	2,688	$2,397

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	14	$981

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$647	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ajsza Matela, MD?

Tedicare shows public-source Medicare data for Ajsza Matela, MD (NPI 1124366869), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajsza Matela, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ajsza Matela, MD?

Ajsza Matela, MD is linked to WESTCHESTER MEDICAL CENTER ADVANCED PHYSICIAN SERVICES, PC (billing NPI 1912131392) in the available physician profile data.

Does Ajsza Matela, MD have Open Payments data?

Ajsza Matela, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.